Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.48 |
| ▸ | FLT3 | P36888 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA3 | P07451 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA6 | P23280 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | DAO | P14920 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30085220 | 1.00 | AOC3 (0.54) | AOC3NPC1RAB9ALOXL2FLT3 | |
| Benzimidazole SCHEMBL28414440 | 0.80 | KDM4E (0.40) | AOC3NPC1RAB9ALOXL2KDM4E | |
| SCHEMBL29631691 | 0.74 | RAB9A (0.74) | AOC3NPC1RAB9ALOXL2FLT3 | |
| SCHEMBL374022 | 0.74 | RAB9A (0.74) | AOC3NPC1RAB9ALOXL2FLT3 | |
| SCHEMBL28593629 | 0.73 | AOC3 (0.52) | AOC3NPC1RAB9ALOXL2FLT3 | |
| SCHEMBL31491477 | 0.73 | DAO (0.60) | AOC3NPC1RAB9AFLT3CYP2A6 | |
| SCHEMBL29377234 | 0.72 | AOC3 (0.56) | AOC3NPC1RAB9ALOXL2FLT3 | |
| SCHEMBL1388385 | 0.70 | AOC3 (0.54) | AOC3NPC1RAB9ALOXL2FLT3 | |
| SCHEMBL274332 | 0.70 | FLT3 (0.59) | AOC3NPC1RAB9ALOXL2FLT3 | |
| SCHEMBL223071 | 0.70 | AOC3 (0.54) | AOC3NPC1RAB9ALOXL2FLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113402553-B | Phosphine ligand of 2-alkyl-indole skeleton, preparation method and application thereof | 香港理工大学深圳研究院 | 2023-06-16 | — | — | CN | disclosed |
| CN-112824422-B | Chiral ferrocene-indole diphosphine ligand as well as preparation method and application thereof | 中国科学院大连化学物理研究所（CN） | 2023-01-13 | — | — | CN | disclosed |
| CN-113402553-A | 2-alkyl-indole skeleton phosphine ligand and preparation method and application thereof | 香港理工大学深圳研究院 | 2021-09-17 | — | — | CN | disclosed |
| WO-2017193288-A1 | SYNTHESIS OF PHOSPHINE LIGANDS BEARING TUNABLE LINKAGE: METHODS OF THEIR USE IN CATALYSIS | THE HONG KONG POLYTECHNIC UNIVERSITY SHENZHEN RESEARCH INSTITUTE (CN) | 2017-11-16 | — | — | WO | disclosed |
| WO-2017193288-A1 | SYNTHESIS OF PHOSPHINE LIGANDS BEARING TUNABLE LINKAGE: METHODS OF THEIR USE IN CATALYSIS | THE HONG KONG POLYTECHNIC UNIVERSITY SHENZHEN RESEARCH INSTITUTE (CN) | 2017-11-16 | — | — | WO | disclosed |
| US-8212056-B2 | Ligands for transition-metals and methods of use | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2012-07-03 | — | — | US | disclosed |
| US-8212056-B2 | Ligands for transition-metals and methods of use | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2012-07-03 | — | — | US | disclosed |
| US-20090326243-A1 | Ligands for transition-metals and methods of use | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2009-12-31 | — | — | US | disclosed |
| US-20090326243-A1 | Ligands for transition-metals and methods of use | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2009-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090326243-A1 | Ligands for transition-metals and methods of use | PDK4, PDXK, PDK3 | AOC3 2369/4885NPC1 3041/4885RAB9A 4038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.